Trial Profile
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Trial of Liraglutide Treatment in Subjects With Newly Diagnosed Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Oct 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms NewLira
- 12 Dec 2019 Status changed from active, no longer recruiting to completed.
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 10 Dec 2018 Planned End Date changed from 1 Oct 2015 to 1 Dec 2018.